The board shall place a drug in Schedule II if it finds that:
(1) the drug has high potential for abuse;
(2) the drug has currently accepted medical use in treatment in the United States or currently accepted medical use with severe restrictions; and
(3) the abuse of the drug may lead to severe psychic or physical dependence.